News Articles Tagged: Preclinical Models

Exploring the Efficacy of GSK2636771 in Preclinical Cancer Models

Investigate the preclinical efficacy of GSK2636771, a selective PI3K beta inhibitor, in various cancer models and its potential in advancing targeted cancer therapies.

CB-839: A Versatile GLS1 Inhibitor for Preclinical Oncology Studies

Discover the preclinical applications of CB-839, a potent glutaminase GLS1 inhibitor, in various cancer models and combination therapies.

Ipatasertib in Vivo: Demonstrating Antitumor Activity in Preclinical Models

Examine the in vivo efficacy of Ipatasertib in preclinical cancer models, highlighting its antitumor effects and the critical role of PUMA.

Preclinical Insights: Selinexor's Anti-Tumor Efficacy in Leukemia Models

Delve into the preclinical evidence demonstrating Selinexor's anti-tumor efficacy in leukemia models, highlighting its potential and the role of companies like NINGBO INNO PHARMCHEM CO.,LTD. in providing research materials.

Exploring the Safety and Efficacy of Novel Obesity Peptides in Animal Models: A Preclinical Review

Examine the preclinical findings on novel obesity peptides, focusing on their safety profile and effectiveness in various animal models, providing insights into their potential for human application.